APR 15, 2017 6:26 PM PDT

Aspirin Therapy Not As Effective As Previously Thought

WRITTEN BY: Kara Marker

How effective is aspirin for treating peripheral vascular disease, really? A large-scale meta-analysis introduces the idea that aspirin could be not very effective at all, potentially even harmful. The new study calls for more experiments to make a definitive statement on the efficacy of aspirin for treating peripheral vascular disease (PVD) and other heart conditions.

PVD consists of blood vessel maladies outside of those in the heart and brain - arteries that carry blood to the limbs, stomach, and kidneys. Two forms of PVD determine a range of possible symptoms; functional PVD involves no physical damage to the blood vessels and is characterized by fluctuating muscle spasms, and organic PVD describes structural changes to blood vessels, causing inflammation and tissue damage. Overall PVD is accompanied by a reduction in blood flow, affecting more than eight million people in the United States.

Aspirin is a classic example of a common drug used to treat heart and blood vessel conditions, like PVD. This drug prevents blood clots from forming, subsequently reducing the risk of adverse cardiac events. However, aspirin’s mechanism of action can backfire, sometimes increasing a person’s risk of hemorrhagic stroke or internal bleeding.

Cardiologist Anthony A Bavry, MD, says that many PVD patients “may not be deriving the benefits from aspirin that they expect to be getting.”

The University of Florida study included a meta-analysis of 11 aspirin therapy trials including more than six thousand PVD patients participating in studies. Statistics gleaned from the 11 trials  showed that aspirin had “no significant effect on death rates and incidents of stroke, heart attack, or major cardiac events.”

"Aspirin might not be a miracle drug for certain patients,” said co-author Ahmed N. Mahmoud, MD. “We need to reconsider the evidence, and see who benefits from aspirin therapy and who does not.”

The present study was published in the journal PLOS One.

Sources: University of Florida, American Heart Association

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 05, 2020
Health & Medicine
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
OCT 05, 2020
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
Even with the best anti-nausea medications one in three patients receiving chemotherapy experiences vomiting, and about ...
OCT 05, 2020
Earth & The Environment
The rising concern of aerosol particles
OCT 05, 2020
The rising concern of aerosol particles
A study from Colorado State University scientists provides insight into the resiliency of aerosol particles, particles f ...
OCT 15, 2020
Immunology
The Immune Cells Giving Menopausal Women Higher BPs
OCT 15, 2020
The Immune Cells Giving Menopausal Women Higher BPs
In general, men have higher blood pressures than women, giving them an increased risk of developing heart disease. After ...
OCT 18, 2020
Cardiology
Many Heart Disease Deaths Are Preventable With Diet Improvements
OCT 18, 2020
Many Heart Disease Deaths Are Preventable With Diet Improvements
New research has suggested that over two-thirds of heart disease cases around the world are preventable with improvement ...
OCT 28, 2020
Cancer
Protecting the Head and Neck from Off Target Radiation
OCT 28, 2020
Protecting the Head and Neck from Off Target Radiation
Radiotherapy alone or with chemotherapy is the go-to treatment for head and neck cancers. Unfortunately, head and neck t ...
OCT 25, 2020
Health & Medicine
Over 4 in 10 People With MS Have Used Cannabis in the Last Year
OCT 25, 2020
Over 4 in 10 People With MS Have Used Cannabis in the Last Year
University of Michigan researchers have found that Americans with Multiple sclerosis (MS) are twice as likely as the gen ...
Loading Comments...